Literature DB >> 24825276

Alagille syndrome with a previously undescribed mutation.

Vidyut Bhatia1, Pawan Kumar.   

Abstract

BACKGROUND: Alagille Syndrome is a rare genetic disease characterized by abnormalities of the intrahepatic biliary ducts with cholestasis along with multisystem anomalies. CASE CHARACTERISTICS: An 8-year old child with persisting jaundice, severe itching and failure to thrive. OBSERVATION: Diagnosis of Alagille syndrome was made on the basis of clinical features, typical facies and liver biopsy showing bile duct paucity. Genetic analysis revealed a novel de novo mutation in the JAG 1 gene. OUTCOME: The child was started on ursodeoxycholic acid following which the itching improved. MESSAGE: A novel de novo mutation in JAG 1 gene is described in this child with Alagille Syndrome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24825276

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  3 in total

1.  A 10-year-old child presenting with syndromic paucity of bile ducts (Alagille syndrome): a case report.

Authors:  Girish Kumar Pati; Ayaskanta Singh; Preetam Nath; Jimmy Narayan; Pradeep Kumar Padhi; Prasanta Kumar Parida; Kaumudee Pattnaik; Chittaranjan Panda; Shivaram Prasad Singh
Journal:  J Med Case Rep       Date:  2016-11-30

2.  Alagille syndrome associated with total anomalous pulmonary venous connection and severe xanthomas: A case report.

Authors:  Han-Shi Zeng; Zhan-Hui Zhang; Yan Hu; Gui-Lang Zheng; Jing Wang; Jing-Wen Zhang; Yu-Xiong Guo
Journal:  World J Clin Cases       Date:  2022-09-06       Impact factor: 1.534

3.  A Novel c.91dupG JAG1 Gene Mutation Is Associated with Early Onset and Severe Alagille Syndrome.

Authors:  Alejandra Del Pilar Reyes-de la Rosa; Gustavo Varela-Fascinetto; Constanza García-Delgado; Edgar Ricardo Vázquez-Martínez; Pedro Valencia-Mayoral; Marco Cerbón; Verónica Fabiola Morán-Barroso
Journal:  Case Rep Genet       Date:  2018-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.